scispace - formally typeset
S

Svein Simonsen

Researcher at Oslo University Hospital

Publications -  167
Citations -  7406

Svein Simonsen is an academic researcher from Oslo University Hospital. The author has contributed to research in topics: Heart transplantation & Transplantation. The author has an hindex of 43, co-authored 165 publications receiving 7128 citations. Previous affiliations of Svein Simonsen include Rikshospitalet–Radiumhospitalet & University of Oslo.

Papers
More filters
Journal ArticleDOI

Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens.

TL;DR: In this article, the authors studied the risk of skin cancer in the complete, single-center Norwegian cohort of kidney and heart transplant recipients (n = 2561) and determined cancer risk estimation by means of standardized incidence ratios and multivariate Cox regression.
Journal ArticleDOI

Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

TL;DR: Deep disturbances in the levels of both inflammatory and anti-inflammatory mediators with a marked dysbalance favoring inflammatory effects are demonstrated in congestive heart failure patients.
Journal ArticleDOI

Elevated Circulating Levels of C-C Chemokines in Patients With Congestive Heart Failure

TL;DR: This first demonstration of increased circulating levels of C-C chemokines in CHF with particularly high levels in patients with severe disease may represent previously unrecognized pathogenic factors inCHF.
Journal ArticleDOI

Determination of Pressure Gradient in Mitral Stenosis with a Non‐invasive Ultrasound Doppler Technique

TL;DR: The investigation demonstrated that the non-invasive ultrasound technique can be used with confidence to gain an impression of the magnitude of the mitral pressure gradient and suggest that deltaPU represents the actual pressure gradient more accurately than deltaPM.
Journal ArticleDOI

Immunomodulating Therapy With Intravenous Immunoglobulin in Patients With Chronic Heart Failure

TL;DR: The main findings were that IVIG, but not placebo, induced a marked rise in plasma levels of the anti-inflammatory mediators interleukin (IL)-10, IL-1 receptor antagonist, and soluble tumor necrosis factor receptors.